Literature DB >> 30707123

Delays in Cardiopulmonary Resuscitation, Defibrillation, and Epinephrine Administration All Decrease Survival in In-hospital Cardiac Arrest.

Nicholas G Bircher1, Paul S Chan, Yan Xu.   

Abstract

WHAT WE ALREADY KNOW ABOUT THIS TOPIC: Rapid response to witnessed, pulseless cardiac arrest is associated with increased survival. WHAT THIS ARTICLE TELLS US THAT IS NEW: Assessment of witnessed, pulseless cardiac arrests occurring at 538 hospitals during a 9-yr period indicates that CPR did not occur immediately at 0 min in 5.7% of patients despite guidelines for instantaneous initiation. Delay in initiation of CPR was associated with significantly decreased survival.Time to initiation of CPR and subsequent time to initiation of administration of defibrillation shock (for shockable arrhythmias) and epinephrine were both associated with reduced patient survival.
BACKGROUND: Because the extent to which delays in initiating cardiopulmonary resuscitation (CPR) versus the time from CPR to defibrillation or epinephrine treatment affects survival remains unknown, it was hypothesized that all three independently decrease survival in in-hospital cardiac arrest.
METHODS: Witnessed, index cases of cardiac arrest from the Get With The Guidelines-Resuscitation Database occurring between 2000 and 2008 in 538 hospitals were included in this analysis. Multivariable risk-adjusted logistic regression examined the association of time to initiation of CPR and time from CPR to either epinephrine treatment or defibrillation with survival to discharge.
RESULTS: In the overall cohort of 57,312 patients, there were 9,802 survivors (17.1%). Times to initiation of CPR greater than 2 min were associated with a survival of 14.7% (91 of 618) as compared with 17.1% (9,711 of 56,694) if CPR was begun in 2 min or less (adjusted odds ratio [95% CI], 0.68 [0.54 to 0.87]; P < 0.002). Times from CPR to either defibrillation or epinephrine treatment of 2 min or less were associated with a survival of 18.0% (7,654 of 42,475), as compared with 15.0% (1,680 of 11,227) for 3 to 5 min (reference, 0 to 2 min; adjusted odds ratios [95% CI], 0.83 [0.78 to 0.88]; P < 0.001), 12.8% (382 of 2,983) for 6 to 8 min (0.67 [0.60 to 0.76], P < 0.001), and 13.7% (86 of 627) for 9 to 11 min (0.54 [0.42 to 0.69], P < 0.001).
CONCLUSIONS: Delays in the initiation of CPR and from CPR to defibrillation or epinephrine treatment were each associated with lower survival.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30707123     DOI: 10.1097/ALN.0000000000002563

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  22 in total

1.  Singapore Advanced Cardiac Life Support Guidelines 2021.

Authors:  Chi Keong Ching; Benjamin Sieu-Hon Leong; Praseetha Nair; Kim Chai Chan; Eillyne Seow; Francis Lee; Kenneth Heng; Duu Wen Sewa; Toon Wei Lim; Daniel Thuan Tee Chong; Khung Keong Yeo; Wee Kim Fong; Venkataraman Anantharaman; Swee Han Lim
Journal:  Singapore Med J       Date:  2021-08       Impact factor: 1.858

2.  Survival outcomes and resuscitation process measures in maternal in-hospital cardiac arrest.

Authors:  Merrill Thomas; Vittal Hejjaji; Yuanyuan Tang; Kevin Kennedy; Anna Grodzinsky; Paul S Chan
Journal:  Am J Obstet Gynecol       Date:  2021-10-22       Impact factor: 10.693

3.  Association Between Hospital Debriefing Practices With Adherence to Resuscitation Process Measures and Outcomes for In-Hospital Cardiac Arrest.

Authors:  Ali O Malik; Brahmajee K Nallamothu; Brad Trumpower; Marci Kennedy; Sarah L Krein; Khaja M Chinnakondepalli; Vittal Hejjaji; Paul S Chan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-17

Review 4.  In-Hospital Cardiac Arrest: A Review.

Authors:  Lars W Andersen; Mathias J Holmberg; Katherine M Berg; Michael W Donnino; Asger Granfeldt
Journal:  JAMA       Date:  2019-03-26       Impact factor: 56.272

5.  Immediate intravenous epinephrine versus early intravenous epinephrine for in-hospital cardiopulmonary arrest.

Authors:  Abdullah Bakhsh; Maha Safhi; Ashwaq Alghamdi; Amjad Alharazi; Bedoor Alshabibi; Rajwa Alobaidi; Maryam Alnashri
Journal:  BMC Anesthesiol       Date:  2021-05-13       Impact factor: 2.217

6.  Can hospital adult code-teams and individual members perform high-quality CPR? A multicenter simulation-based study incorporating an educational intervention with CPR feedback.

Authors:  Jesse M Rideout; Edwin T Ozawa; Darlene J Bourgeois; Micheline Chipman; Frank L Overly
Journal:  Resusc Plus       Date:  2021-06-12

7.  Cerebrospinal fluid is a significant fluid source for anoxic cerebral oedema.

Authors:  Ting Du; Humberto Mestre; Benjamin T Kress; Guojun Liu; Amanda M Sweeney; Andrew J Samson; Martin Kaag Rasmussen; Kristian Nygaard Mortensen; Peter A R Bork; Weiguo Peng; Genaro E Olveda; Logan Bashford; Edna R Toro; Jeffrey Tithof; Douglas H Kelley; John H Thomas; Poul G Hjorth; Erik A Martens; Rupal I Mehta; Hajime Hirase; Yuki Mori; Maiken Nedergaard
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

8.  2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 4. Adult advanced life support.

Authors:  Jaehoon Oh; Kyoung-Chul Cha; Jong-Hwan Lee; Seungmin Park; Dong-Hyeok Kim; Byung Kook Lee; Jung Soo Park; Woo Jin Jung; Dong Keon Lee; Young Il Roh; Tae Youn Kim; Sung Phil Chung; Young-Min Kim; June Dong Park; Han-Suk Kim; Mi Jin Lee; Sang-Hoon Na; Gyu Chong Cho; Ai-Rhan Ellen Kim; Sung Oh Hwang
Journal:  Clin Exp Emerg Med       Date:  2021-05-21

9.  Intramuscular adrenaline for out-of-hospital cardiac arrest is associated with faster drug delivery: A feasibility study.

Authors:  A E Pugh; H H Stoecklein; J E Tonna; G L Hoareau; M A Johnson; S T Youngquist
Journal:  Resusc Plus       Date:  2021-05-31

10.  Sports safety matting diminishes cardiopulmonary resuscitation quality and increases rescuer perceived exertion.

Authors:  Thomas Kingston; Nicholas B Tiller; Elle Partington; Mukhtar Ahmed; Gareth Jones; Mark I Johnson; Nigel A Callender
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.